Order Article Reprints

Pelland A-A, Dumas M, Lemieux-Blanchard É, LeBlanc R, Côté J, Boudreault J-S, Duquette D, Kaedbey R, Lalancette M, Larose F, et al. Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma. Current Oncology. 2025; 32(4):238. https://doi.org/10.3390/curroncol32040238

Pelland, Andrée-Anne, Mathilde Dumas, Émilie Lemieux-Blanchard, Richard LeBlanc, Julie Côté, Jean-Samuel Boudreault, Dominic Duquette, Rayan Kaedbey, Marc Lalancette, Frédéric Larose, and et al. 2025. "Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma" Current Oncology 32, no. 4: 238. https://doi.org/10.3390/curroncol32040238

Pelland, A.-A., Dumas, M., Lemieux-Blanchard, É., LeBlanc, R., Côté, J., Boudreault, J.-S., Duquette, D., Kaedbey, R., Lalancette, M., Larose, F., Nikonova, A., Pavic, M., Shamy, A., Roy, J., Sebag, M., Trudel, S., & Claveau, J.-S. (2025). Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma. Current Oncology, 32(4), 238. https://doi.org/10.3390/curroncol32040238